TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06376435

Intervention type: DRUG
Intervention: Herombopag Olamine Tablets
Description: Herombopag Olamine；combined rhTPO;combined IL-11

Intervention type: DRUG
Intervention: Herombopag Olamine Tablets
Description: Herombopag Olamine；combined rhTPO;combined IL-11

Intervention type: DRUG
Intervention: Herombopag Olamine Tablets
Description: Herombopag Olamine；combined rhTPO;combined IL-11
Study: NCT04851535

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Jaktinib Hydrochloride Tablets
Description: Jaktinib 100mg Bid
Study: NCT06102681

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: intervention group
Description: we will measure, consider and compare patients pain level, quality of life and recovery process. For these aims we will use numeric pain scale, nottingham health profile and postoperative recovery index.
Study: NCT05669183

Intervention type: PROCEDURE
Intervention: Veno-arterial extracorporeal membrane oxygenation
Description: Veno-arterial extracorporeal membrane oxygenation (VA ECMO) is mainly used for circulatory support in patients with severe cardiopulmonary failure. VA ECMO drains the blood from the venous system followed pumping the blood back into the arterial vascular compartment after oxygenation. It can be divided into two cannulation strategies for VA ECMO support, namely peripheral VA ECMO and central VA ECMO based on the arterial cannulation site. Peripheral VA ECMO is established via the femoral artery (FA), whereas axillary artery (AX) is an arterial cannulation site in central VA-ECMO.

Intervention type: PROCEDURE
Intervention: Veno-arterial extracorporeal membrane oxygenation
Description: Veno-arterial extracorporeal membrane oxygenation (VA ECMO) is mainly used for circulatory support in patients with severe cardiopulmonary failure. VA ECMO drains the blood from the venous system followed pumping the blood back into the arterial vascular compartment after oxygenation. It can be divided into two cannulation strategies for VA ECMO support, namely peripheral VA ECMO and central VA ECMO based on the arterial cannulation site. Peripheral VA ECMO is established via the femoral artery (FA), whereas axillary artery (AX) is an arterial cannulation site in central VA-ECMO.
Study: NCT05399836

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Portion size manipulation
Description: The intervention will be administered via changing portion sizes of foods served to participants.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Portion size manipulation
Description: The intervention will be administered via changing portion sizes of foods served to participants.
Study: NCT04193605

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mindfulness
Description: The traditional MBSR intervention consists of the following: (1) a series of eight weekly session of 2.5 to 3 hours; (2) a silent retreat during the sixth week; (3) daily home assignments including formal and informal mindfulness practices; and (4) didactic presentations on stress and the consequences of stress. We are culturally tailoring the intervention with the goal of maintain fidelity.
Study: NCT04416191

Intervention type: OTHER
Group type: OTHER
Intervention: Limb immobilization
Description: Participants will undergo a 2-week period of leg immobilization
Study: NCT06371326

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZT002 Injection
Description: Participants will receive ZT002 by subcutaneous (SC) injection.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will receive Placebo by subcutaneous (SC) injection.
Study: NCT04955652

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Maintenance Topic
Description: Alert

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health Maintenance Topic
Description: Alert

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Actionable Sidebar Item
Description: Alert

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Actionable Sidebar Item
Description: Alert

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Best Practice Alert
Description: Alert
Study: NCT06362928

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ATC System
Description: The ATC System is designed to mechanically remove emboli and restore blood flow through the pulmonary arteries in patients experiencing acute PE
Study: NCT04702308

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical Decision Rule Alerts
Description: The
Study: NCT06474273

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methylprednisolone
Description: IV Methylprednisolone

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methylprednisolone
Description: IV Methylprednisolone

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Description: IV Methylprednisolone

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Description: IV Methylprednisolone

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prednisone
Description: Oral prednisone augmentation

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prednisone
Description: Oral prednisone augmentation

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: Oral prednisone augmentation

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: Oral prednisone augmentation
Study: NCT06380881

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-2017
Description: SHR-2017
Study: NCT05551871

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Simvastatin
Description: the patient will receive Simvastatin for 7 days

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo drug
Description: the patient will receive Placebo drug for 7 days
Study: NCT06069115

Intervention type: RADIATION
Intervention: Radiation therapy protocol for Breast cancer
Description: Conformal 3D radiation therapy will be performed 4-12 weeks after surgical treatment of breast cancer on Electa Axesse linear gas pedal with 6 MeV energy in traditional fractionation mode. Different RT schemes will be used depending on the stage of the disease, type of surgical treatment, and morphological variant of the tumor. In organ-preserving surgeries the remaining breast will be irradiated with a single focal dose (FD) of 2 Gy, up to the total focal dose (TFD) of 50 Gy. In the presence of risk factors, irradiation of lymphatic outflow pathways will be performed: axillary, sub/adclavicular and parasternal lymph nodes areas (FD 2 Gy, up to TFD 44-46 Gy). In radical breast resection we'll use irradiation of the anterior chest wall in 2 Gy FD, up to 50 Gy FD, irradiation of lymphatic outflow pathways: axillary, sub/adclavicular and parasternal lymph nodes (2 Gy FD, up to 44-46 Gy FD).
Study: NCT05292495

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HR17031 injection
Description: HR17031 injection; administered subcutaneously.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HR17031 injection
Description: HR17031 injection; administered subcutaneously.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HR17031 injection
Description: HR17031 injection; administered subcutaneously.
Study: NCT06069115

Intervention type: DIAGNOSTIC_TEST
Intervention: Spirography and assessment of pulmonary diffusion capacity
Description: Using the Master Screen Body device you will be asked to take two series of breaths through a special tube for 2-3 minutes. Usually the procedure does not cause any discomfort

Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiopulmonary stress test
Description: The exercise test is performed on a bicycle ergometer Oxycon Pro. Prior to the test, special sensors for recording the electrocardiogram, a sensor to determine blood saturation, and a cuff to measure blood pressure will be glued on the body. Breathing during the test takes place through a face mask with a built-in gas analyzer sensor. The stress test is conducted up to an individual maximum (according to the age, sex, height and weight of the patient), followed by a recovery period. There is some temporary discomfort associated with performing physical activity. Dyspnea, leg fatigue, and dizziness may occur. Observation continues until full recovery of hemodynamic and gas exchange parameters, in case of appearance of unfavorable symptoms - until their disappearance.

Intervention type: DIAGNOSTIC_TEST
Intervention: Computed tomography of the chest organs
Description: CT is a method of examination based on X-rays, but unlike conventional X-rays, it gives the most complete picture of the body structure, with less radiation.~Tomography usually does not cause any unpleasant feelings and is performed in a specialized department.

Intervention type: DIAGNOSTIC_TEST
Intervention: SF-36 Quality of Life Questionnaire
Description: Standard questionnaire for assessment quality of patient's life https://clinmedjournals.org/articles/jmdt/jmdt-2-023-figure-1.pdf

Intervention type: DIAGNOSTIC_TEST
Intervention: Demographic and anthropometric measures
Description: Age, sex, height. weight, body mass index (BMI)

Intervention type: OTHER
Intervention: Indicators characterizing the severity of the underlying disease
Description: Severity of underlying disease (mMRC, BODE, SMRT-CO Respiratory Support Need Scale), and comorbidities (cardiovascular disease, diabetes mellitus, chronic obstructive pulmonary disease, chronic kidney disease) Medications taken.
Study: NCT05744141

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Relaxation Exercises
Description: Relaxation exercises consist of voluntary, rhythmic and regular stretching and relaxation of large and small muscle groups until the whole body relaxes. For this exercise application, the Relaxation Exercises CD prepared by the Turkish Psychological Association will be used. The CD consists of 30 minutes and relaxation exercises are explained with the sound of a stream accompanied by verbal instructions. This exercise includes rhythmic breathing, muscle relaxation exercises and music (stream sound).
Study: NCT05250011

Intervention type: DRUG
Intervention: Dapagliflozin
Description: Dapagliflozin, prescribed as per approved indication and current medical practice. Participants will not receive any experimental disease management intervention or experimental treatment as a consequence of their participation in the study.
Study: NCT04251520

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Pharmacogenomics testing
Description: Participants will undergo pharmacogenomics testing and will be asked to provide a one-time buccal scraping. These results will be utilized for clinical treatment decisions.
Study: NCT06263608

Intervention type: DEVICE
Group type: OTHER
Intervention: (Cardio)Respiratory polygraphy (NOX T3s)
Description: This home-based device enables the detection of obstructive sleep apnea by calculating the apnea hypopnea index (AHI).

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Polysomnography
Description: Polysomnography allows both sleep and respiration monitoring during an overnight stay in a dedicated sleep clinic.

Intervention type: DEVICE
Group type: OTHER
Intervention: Devices to deliver Continuous Positive Airway Pressure (CPAP), Bilevel Positive Airway Pressure (BiPAP) or Adaptive support ventilation (ASV)
Description: Devices can be used to deliver CPAP, BiPAP, or ASV treatment to open up the airways, making breathing during sleep possible.

Intervention type: DEVICE
Group type: OTHER
Intervention: Fitbit smartwatch
Description: The smartwatch enables the semi-continuous monitoring of the heart rhythm via the installed FibriCheck algorithm.
Study: NCT04251520

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pharmacist review
Description: Participants will have their medical information, including patient demographics, problem list, medication list, allergies, and relevant lab work reviewed by a One Point pharmacist. The pharmacist will work with the Palliative Medicine team to make medication related recommendations to improve individual patient care. The pharmacist will call the patient roughly 48 hours following their outpatient consultation or hospital discharge to review the medication list and address any medication-related questions. The pharmacy will send refill reminders to the patients.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pharmacist review
Description: Participants will have their medical information, including patient demographics, problem list, medication list, allergies, and relevant lab work reviewed by a One Point pharmacist. The pharmacist will work with the Palliative Medicine team to make medication related recommendations to improve individual patient care. The pharmacist will call the patient roughly 48 hours following their outpatient consultation or hospital discharge to review the medication list and address any medication-related questions. The pharmacy will send refill reminders to the patients.
Study: NCT06482632

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Discectomy of Omohyoid
Description: Will be removing the Omohyoid during an anterior cervical discectomy and fusion to compare its effect of dysphagia.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Control group no discectomy of Omohyoid
Description: Will not be removing the Omohyoid during an anterior cervical discectomy and fusion to compare its effect of dysphagia.
Study: NCT05438914

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Repair of the subscapularis
Description: The subscapularis will be repaired using the suture through bone and prosthesis holes surgical technique.
Study: NCT05738317

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel
Description: Adebrelimab is recommended to be administered with an infusion pump. The infusion pipeline is equipped with a 0.22-micron online filter membrane. Intravenous injection or bolus injection is not allowed. At the end of infusion, flush the infusion tube with sufficient 5% glucose or physiological saline, and do not share the same infusion tube with other drugs. In each treatment cycle, Adebrelimab should be given intravenously first.
Study: NCT05668585

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CFT1946
Description: Specified oral dose on specified day

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CFT1946
Description: Specified oral dose on specified day

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CFT1946
Description: Specified oral dose on specified day

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CFT1946
Description: Specified oral dose on specified day

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CFT1946
Description: Specified oral dose on specified day

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CFT1946
Description: Specified oral dose on specified day

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trametinib
Description: Specified oral dose on specified day

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trametinib
Description: Specified oral dose on specified day

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: Specified intravenous dose on specified day

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: Specified intravenous dose on specified day
Study: NCT06500624

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pizotifen
Description: Each subject will be given 0.5mg pizotifen with 10-20mg escitalopram in patients with depressive disorder
Study: NCT05289973

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TruNatomy Files
Description: Newly introduced endodontic file with high flexibility.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HyFlex EDM Files
Description: Endodontic files
Study: NCT06010992

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nitazoxanide
Description: Nitazoxanide oral capsules 500 mg twice daily
Study: NCT05597111

Intervention type: DIAGNOSTIC_TEST
Intervention: DHA levels of blood and cervical mucus
Description: DHA levels of blood and cervical mucus of the control and the study groups will be measure

Intervention type: DIAGNOSTIC_TEST
Intervention: DHA levels of blood and cervical mucus
Description: DHA levels of blood and cervical mucus of the control and the study groups will be measure
Study: NCT05938608

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Regimen 1 (Oral primaquine)
Description: Primaquine 15 mg base orally once

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Regimen 2 (IV primaquine phosphate)
Description: Primaquine 7.5 mg base in normal saline 500 mL infused over 30 minutes intravenously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Regimen 3 (IV carboxyprimaquine)
Description: Carboxyprimaquine 7.93 mg base in normal saline 500 mL infused over 30 minutes intravenously
Study: NCT04773301

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levobupivacaine
Description: Local anaesthetic drug belonging to the amino amide group. It is the S-enantiomer of bupivacaine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ropivacaine
Description: Local anaesthetic drug belonging to the amino amide group. The name ropivacaine refers to both the racemate and the marketed S-enantiomer.
Study: NCT06049979

Intervention type: OTHER
Intervention: Acute gastrointestinal injury
Description: AGIUS score\>2
Study: NCT05386030

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: saypha® VOLUME Lidocaine
Description: Crosslinked hyaluronic acid (HA) 23 mg/mL + 0.3% lidocaine hydrochloride.

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Juvéderm® Voluma™ XC
Description: Crosslinked HA 20 mg/mL + 0.3% lidocaine hydrochloride
Study: NCT06262802

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active decompression
Description: Intracystic active negative pressure

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active decompression
Description: Intracystic active negative pressure
Study: NCT04780282

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Scapular Stabilization Group
Description: Participants will apply the 5 exercises given.
Study: NCT04994886

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Device implantation
Description: The intervention involves the insertion of 2 lead electrodes (Specify Surescan 5-6-5 Leads, Model 977C190 Medtronic) epidurally over the dorsal aspect of the spinal cord through 2 laminectomies and two implantable pulse generators (Intellis™ with AdaptiveStim™, Model 97715 Medtronic) in the abdomen of the participant.
Study: NCT06508697

Intervention type: DIAGNOSTIC_TEST
Intervention: invasive coronary angiography (ICA) with fractional flow reserve (FFR) pressure measurement
Description: A consecutive series of patients who underwent Coronary computed tomography angiography (CTA) within 90 days before invasive coronary angiography (ICA) with fractional flow reserve (FFR) pressure measurement were candidates for this study at Fujita Health University Hospital, Bantane Hospital, and Nagoya First Red Cross Hospital
Study: NCT05990140

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: peppermint flavored mouthwash
Description: The Effect of Peppermint Flavored Mouthwash Applied to Patients in the First 30 Days After Bariatric Surgery on Nausea-Vomiting, Anxiety and Biochemical Parameters
Study: NCT06404229

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: CardioPulmonary Exercise Testing
Description: CardioPulmonary Exercise Testing using an arm ergometer prior to surgery
Study: NCT06423001

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: PostbiotiX Slowing 4 g sachets PostbiotiX Slowing is a food supplement based on Fermented FOS from Lactobacillus paracasei CNCM I-5220.
Description: Each patient will be supplied with the investigational product at Visit 0, PostibiotiX Slowing and at visit 3, based on the outcome of the randomization at V0 (Sequence AB, PostbiotiX Slowing/Placebo; Sequence BA, Placebo/PostbiotiX Slowing).

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: PostbiotiX Slowing 4 g sachets PostbiotiX Slowing is a food supplement based on Fermented FOS from Lactobacillus paracasei CNCM I-5220.
Description: Each patient will be supplied with the investigational product at Visit 0, PostibiotiX Slowing and at visit 3, based on the outcome of the randomization at V0 (Sequence AB, PostbiotiX Slowing/Placebo; Sequence BA, Placebo/PostbiotiX Slowing).
Study: NCT05522543

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional treatment with Passive translatoric intervertebral glides
Description: Patient education (Postural correction, lifting, sitting and sleeping positions) • Hot Pack 10 mins~• PA Glides (Central and Transverse mobilizations) (10 sec each) x5 sets • Core stabilization exercise (Knee to chest, bridges, prone press ups, cat and camel stretches) • Home plan (bridges, knee to chest, cat and camel stretch and prone press ups

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional treatment with manual segmental lumbar traction
Description: Patient education (Postural correction, lifting, sitting and sleeping positions) • Hot Pack 10 mins~• Manual lumbar Traction (L1-L5) for 15-20 sec x5 sets • Lumbar facet gapping (LFG) in side lying (10 sec 3 sets) and Lumbar rotational facet gapping (LRFG) in side lying (10 sec 3 sets) • .Core stability exercises (Knee to chest, bridges, prone press ups, cat and camel stretches) • Home plan